Opinions Archives

August 9, 2023

Response to Dr. Jha’s “A Positive Covid Milestone”

The immunocompromised/immunosuppressed community joins Dr. Jha in the New York Times article and all of society in celebrating “A Positive COVID Milestone”

May 25, 2023

Opinion: The FDA is Making it More Difficult for New Drugs to be Approved. Why CLL / SLL Patients Should Care.

CLL / SLL patients have greatly benefited from breakthroughs in understanding the disease’s biology and the resulting new targeted therapies.

April 14, 2023

Toxic Exposure: Does Exposure to Roundup Cause CLL / SLL and Other Lymphoma?

Dr. Nabhan explains what led him to his strong conviction that Roundup increased the risk for NHL.

April 13, 2023

Dr. Ed Ratner’s Review of For Blood and Money by Nathan Vardi

Dr. Ed Ratner’s Review of For Blood and Money by Nathan Vardi that chronicles the development of two blockbuster drugs

April 13, 2023

For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug: An Interview With the Author About the Development of Ibrutinib and Acalabrutinib

I am grateful to Nathan Vardi for illuminating this incredible story’s corners, and I highly recommend his book.

April 13, 2023

Excerpt from For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

Evusheld may not have been our perfect get-out-of-jail-free card, like in the game of Monopoly, during the last year. Still, it did provide a similar and perhaps superior degree of safety for the CLL / SLL community compared to that afforded by vaccinations in our friends with a normal immune systems.

February 3, 2023

Goodbye, Evusheld, and Thanks for the Memories

September 22, 2022

Are the Ever-Changing COVID-19 Variants of Concern (VOC) Going to Eventually Negate Any and All Protection That CLL / SLL Patients Might Have Received from the Vaccines and Evusheld?

What follows is just my opinion. Data are thin in many areas, but there are also some areas of solid research to guide us.

April 21, 2022

COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical Resources: Moving CLL / SLL and Other Immunocompromised Patients to the Top Tier

In a pandemic with scarce resources, governments, medical institutions, and healthcare providers have had to make decisions and/or policies about allocating potentially lifesaving therapies among the many outpatients who might benefit from them.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Opinions

Response to Dr. Jha’s “A Positive Covid Milestone”

Opinion: The FDA is Making it More Difficult for New Drugs to be Approved. Why CLL / SLL Patients Should Care.

Toxic Exposure: Does Exposure to Roundup Cause CLL / SLL and Other Lymphoma?

Dr. Ed Ratner’s Review of For Blood and Money by Nathan Vardi

For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug: An Interview With the Author About the Development of Ibrutinib and Acalabrutinib

Excerpt from For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

Goodbye, Evusheld, and Thanks for the Memories

Are the Ever-Changing COVID-19 Variants of Concern (VOC) Going to Eventually Negate Any and All Protection That CLL / SLL Patients Might Have Received from the Vaccines and Evusheld?

COVID-19 Vaccine Refusal and Fair Allocation of Scarce Medical Resources: Moving CLL / SLL and Other Immunocompromised Patients to the Top Tier

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT CLL SOCIETY

CONTACT